首页> 外国专利> MODELLING IN YEAST OF THE MITOCHONDRIAL ATP6 GENE MUTATIONS RESPONSIBLE FOR NARP SYNDROME IN HUMANS AND USES THEREOF FOR SCREENING FOR MEDICAMENTS

MODELLING IN YEAST OF THE MITOCHONDRIAL ATP6 GENE MUTATIONS RESPONSIBLE FOR NARP SYNDROME IN HUMANS AND USES THEREOF FOR SCREENING FOR MEDICAMENTS

机译:酵母中对人类NARP综合征负责的线粒体ATP6基因突变的建模及其在药物筛选中的用途

摘要

Modified yeast cells comprising at least one mutation of the tryptophan 136 (W136), leucine 183 (L183), or leucine 247 (L247) codon of the mitochondrial ATP6 gene, responsible for NARP syndrome in humans and uses thereof for screening for medicaments that act against mitochondrial pathologies involving a deficiency in ATP production via the oxidative phosphorylation pathway, such as NARP syndrome.
机译:修饰的酵母细胞,其至少包含线粒体ATP6基因的色氨酸136(W136),亮氨酸183(L183)或亮氨酸247(L247)密码子的突变,负责人的NARP综合征及其在筛选可起作用的药物中的用途对抗线粒体病理学,该线粒体病理学涉及通过氧化磷酸化途径的ATP生成不足,例如NARP综合征。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号